Lyra Therapeutics (LYRA) Enterprise Value (QoQ) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Lyra Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.94% |
| Sep 30, 2025 | 25.95% |
| Jun 30, 2025 | 6.15% |
| Mar 31, 2025 | 21.79% |
| Dec 31, 2024 | 24.32% |
| Sep 30, 2024 | 22.85% |
| Jun 30, 2024 | 21.99% |
| Mar 31, 2024 | 14.45% |
| Dec 31, 2023 | -0.20% |
| Sep 30, 2023 | -32.54% |
| Jun 30, 2023 | 6.76% |
| Mar 31, 2023 | 15.28% |
| Dec 31, 2022 | 10.80% |
| Sep 30, 2022 | 9.08% |
| Jun 30, 2022 | -259.16% |
| Mar 31, 2022 | 26.03% |
| Jun 30, 2020 | -145.69% |
| Mar 31, 2020 | -259.37% |